Clopidogrel	Placebo	First hemodialysis success	1228	1356	First hemodialysis from newly created AVF in clopidogrel group was significantly more successful than placebo group (P = 0.008).
Clopidogrel	Placebo	Complications and mortality	-1	-1	Complication <TAB> All patients (%) <TAB> Clopidogrel (%) <TAB> Placebo (%) <TAB> P valueGI bleeding <TAB> 5 (5.3) <TAB> 2 (2.1) <TAB> 3 (3.2) <TAB> 0.31Non GI tract bleeding <TAB> 9 (9.6) <TAB> 5 (5.3) <TAB> 4 (4.3) <TAB> 0.63Death events <TAB> 4 (4.3) <TAB> 2 (2.1) <TAB> 2 (2.1) <TAB> 0.47
Clopidogrel	Placebo	The primary arteriovenous fistula failures at two months	916	1024	The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03).
Clopidogrel	Placebo	Complications and mortality	-1	-1	<td align="left" colspan="1" rowspan="1">Death events</td><td align="center" colspan="1" rowspan="1">4 (4.3)</td><td align="center" colspan="1" rowspan="1">2 (2.1)</td><td align="center" colspan="1" rowspan="1">2 (2.1)</td><td align="center" colspan="1" rowspan="1">0.47</td>
